Caricamento...
Rituximab in Neuromyelitis Optica Spectrum Disorders: Our Experience
BACKGROUND: Neuromyelitis optica (NMO) is an inflammatory demyelinating central nervous system disease, with recurrent attacks of severe bilateral optic neuritis and longitudinally extensive transverse myelitis. Aggressive immunosuppression is essential to prevent clinical relapses and permanent dis...
Salvato in:
| Pubblicato in: | Ann Indian Acad Neurol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5586117/ https://ncbi.nlm.nih.gov/pubmed/28904454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aian.AIAN_499_16 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|